Calpain inhibition as a potential treatment of Alzheimer's disease

American Journal of Pathology

Volumn 181, Issue 2, 2012, Pages 388-391

  Getz, Godfrey S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 705253; AMYLOID BETA PROTEIN; BDA 410; CALPAIN; ENZYME INHIBITOR; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN SLICE; ENZYME INHIBITION; LEARNING; MEMORY; NEUROPROTECTION; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AGING; ALZHEIMER DISEASE; ANIMALS; BENZAMIDES; COGNITION; GLYCOPROTEINS; HUMANS;

EID: 84864117787     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.04.027     Document Type: Note

References (22)

1. H.W. Querfurth, F.M. LaFerla Alzheimer's Disease N Engl J Med 362 2010 329 344
2. R. Medeiros, M. Kitagawa, M. Chabrier, D. Cheng, D. Baglietto-Vargas, A. Kling, A. Moeller, K.N. Green, F.M. LaFerla Calpain inhibitor A-705253 mitigates Alzheimer's disease like pathology and cognitive decline in aged 3xTgAD mice Am J Pathol 181 2012 616 625
3. D.E. Goll, V.F. Thompson, H. Li, W. Wei, J. Gong The Calpain System Physiol Rev 83 2003 731 801
4. K.N. Green, F.M. LaFerla Linking calcium to Aβ and Alzheimer's disease Neuron 59 2008 190 194
5. K. Saito, J.S. Elce, J.E. Hamos, R.A. Nixon Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer's disease: a potential molecular basis of neuronal degeneration Proc Natl Acad Sci USA 90 1993 2628 2632
6. M.V. Rao, P.S. Mohan, C.M. Peterhoff, D.S. Yang, S.D. Schmidt, P.H. Stavrides, J. Campbell, Y. Chen, Y. Jiang, P.A. Paskevich, A.M. Cataldo, V. Haroutunian, R.A. Nixon Calpastatin depletion (CAST) in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST expression J Neurosci 28 2008 12241 12254
7. M. Higuchi, N. Iwata, Y. Matsuba, J. Takamo, T. Suemoto, J. Maeda, B. Ji, M. Ono, M. Staufenbiel, T. Suhara, T.C. Saido Mechanistic involvement of the calpain-calpastatin system in Alzheimer's neuropathology FASEB J 26 2012 1204 1217
8. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, F.M. LaFerla Triple transgenic model of Alzheimer's disease with plaques and tangles; intracellular Aβ and synaptic dysfunction Neuron 39 2003 409 421
9. W. Lubisch, E. Beckenbach, S. Bopp, H.P. Hoffman, A. Kartal, C. Kastel, T. Lindner, M. Metz-Garrecht, J. Reeb, F. Regner, M. Vierling, Moller Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability J Med Chem 46 2003 2402 2412
10. R.C. Sinjoanu, S. Kleinschmidt, R.S. Bitner, J.D. Brioni, A. Moeller, A. Ferreira The novel calpain inhibitor A 705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons Neurochem Int 13 2008 359 369
11. I. Granic, C. Nyskas, P.G. Luiten, U.L. Eisel, L.G. Halmy, G. Gross, H. Schoemaker, A. Moller, V. Nimmrich Calpain inhibition prevents amyloid β-induced neurodegeneration and associated behavioral dysfunction in rats Neuropharmacology 59 2010 334 342
12. V. Nimmrich, K.G. Reymann, M. Strassburger, U.H. Schoder, G. Gross, A. Hahn, H. Schoemaker, K. Wicke, A. Moller Inhibition of calpain prevents NMDA-induced cell death and β-amyloid-induced synaptic dysfunction in hippocampal slice cultures Br J Pharmacol 159 2010 1523 1531
13. W. Ma, W. Han, P.A. Greer, R.M. Tuder, H.A. Toque, K.K. Wang, R.W. Caldwell, Y. Su Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension and its inhibition attenuates pathological features of disease J Clin Invest 121 2011 4548 4566
14. J.D. Johnson, K. Otani, G.I. Bell, K.S. Polonsky Impaired insulin secretion in transgenic mice over expressing calpastatin in pancreatic beta cells Islets 1 2009 242 248
15. B. Liang, B.Y. Duan, X.P. Zhou, J.X. Gong, Z.G. Luo Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer's disease J Biol Chem 277 2010 27737 27744
16. S.E. Wahrle, H. Jiang, M. Parsadanian, J. Kim, A. Li, A. Knoten, S. Jain, V. Hirsch-Reinshagen, C.L. Wellington, K.R. Bales, S.M. Paul, D.M. Holtzman Overexpression of ABCA1 reduces amyloid deposition in PDAPP mouse model of Alzheimer's disease J Clin Invest 118 2008 671 682
17. L.O. Martinez, B. Agerholm-Larsen, N. Wang, W. Chen, A.R. Tall Phosphorylation of a PEST sequence in ABCA1 promotes calpain degradation and is reversed by apo A-I J Biol Chem 278 2003 37366 37374
18. Q. Jiang, C.Y.D. Lee, S. Mandrekar, B. Wilkinson, P. Cramer, N. Zelcer, K. Mann, B. Lamb, T.M. Willson, J.L. Collins, T.C. Richardson, J.D. Smith, T.A. Comery, D. Riddell, D.M. Holtzman, P. Tontonoz, G.E. Landreth ApoE promotes the proteolytic degradation of Aβ Neuron 58 2008 681 693
19. F. Trinchese, M. Fa, S. Liu, H. Zhang, A. Hidalgo, S.D. Schmidt, H. Yamaguchi, N. Yoshii, P.M. Mathews, R.A. Nixon, O. Arancio Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer's disease J Clin Invest 118 2008 2796 2807
20. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, M. Figurski, E. Coart, K. Biennow, H. Soares, A.J. Simon, P. Leweczuk, R.A. Dean, E. Siemers, W. Potter, V.M. Lee, J.Q. Trojanowski Alzheimer's Disease Neuroimaging Initiative: Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI Acta Neuropathol 121 2011 597 609
21. D.W. Wesson, A.H. Borkowski, G.E. Landreth, R.A. Nixon, E. Levy, D.A. Wilson Sensory network dysfunction, behavioral impairments and their reversibility in an Alzheimer's β-amyloidosis mouse model J Neurosci 31 2011 15962 15971
22. D.W. Wesson, E. Levy, R.A. Nixon, D.A. Wilson Olfactory dysfunction correlates with amyloid-β burden in an Alzheimer's disease mouse model J Neurosci 30 2010 505 514